文献速递甲状腺疾病

探索甲状腺功能障碍与常见精神疾病之间的遗传联系:特异性激素还是普遍性自身免疫共病

Exploring the Genetic Link Between Thyroid Dysfunction and Common Psychiatric Disorders: A Specific Hormonal or a General Autoimmune Comorbidity.
PubMed 文献 · Thyroid · 2023-01-01

研究基于英国生物银行497,726名受试者的表型和基因型数据,分析甲状腺疾病与抑郁、双相障碍及焦虑障碍的关系。结果显示甲状腺功能减退与重性抑郁障碍、双相障碍和焦虑障碍风险升高相关,甲状腺功能亢进与重性抑郁障碍和焦虑障碍相关。甲状腺疾病与重性抑郁障碍及焦虑障碍存在强遗传共遗传性,集中于6号染色体主要组织相容性复合体区域,而促甲状腺激素和游离甲状腺素水平与心境障碍无遗传相关。

要点

  • 甲状腺功能减退与重性抑郁障碍(OR=1.31)、双相障碍(OR=1.55)和焦虑障碍(OR=1.16)风险升高相关。
  • 甲状腺功能亢进与重性抑郁障碍(OR=1.11)和焦虑障碍(OR=1.34)相关。
  • 甲状腺疾病与重性抑郁障碍及焦虑障碍的遗传相关性集中于6号染色体主要组织相容性复合体区域,自身免疫可能起重要作用。

核心结论

  • 研究发现自身免疫性甲状腺功能减退与心境障碍之间存在潜在关联,该关联并非由甲状腺激素介导,自身免疫起突出作用。
  • 这些发现可能为治疗精神疾病中甲状腺功能(轻微)变化潜在无效提供新见解,但需进一步研究确定确切分子机制。

研究设计与样本

  • 研究对多个表型和基因型数据库进行全面分析,纳入英国生物银行497,726名受试者。
  • 分析甲状腺疾病与抑郁、双相障碍和焦虑障碍的关系,并探究甲状腺疾病、促甲状腺激素和游离甲状腺素水平与精神疾病全基因组易感因素的遗传相关性,进一步定位至特定局部基因组区域。

主要发现

  • 甲状腺功能减退与重性抑郁障碍风险升高相关(OR=1.31,p=5.29×10-89),与双相障碍相关(OR=1.55,p=0.0038),与焦虑障碍相关(OR=1.16,p=6.22×10-8)。
  • 甲状腺功能亢进与重性抑郁障碍相关(OR=1.11,p=0.0034),与焦虑障碍相关(OR=1.34,p=5.99×10-6)。
  • 甲状腺疾病与重性抑郁障碍存在强共遗传性(rg=0.17,p=2.7×10-4),与焦虑障碍存在强共遗传性(rg=0.17,p=6.7×10-6)。
  • 遗传相关性在6号染色体主要组织相容性复合体位点尤其强(p<10-5),但进一步分析显示基因组其他部分也贡献于该全局效应。
  • 促甲状腺激素和游离甲状腺素水平均与心境障碍无遗传相关性。

局限性

  • 原文未报告局限性,但结论指出需进一步研究确定确切的潜在分子机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The hypothalamus-pituitary-thyroid axis coordinates brain development and postdevelopmental function. Thyroid hormone (TH) variations, even within the normal range, have been associated with the risk of developing common psychiatric disorders, although the underlying mechanisms remain poorly understood. Methods: To get new insight into the potentially shared mechanisms underlying thyroid dysfunction and psychiatric disorders, we performed a comprehensive analysis of multiple phenotypic and genotypic databases. We investigated the relationship of thyroid disorders with depression, bipolar disorder (BIP), and anxiety disorders (ANXs) in 497,726 subjects from U.K. Biobank. We subsequently investigated genetic correlations between thyroid disorders, thyrotropin (TSH), and free thyroxine (fT4) levels, with the genome-wide factors that predispose to psychiatric disorders. Finally, the observed global genetic correlations were furthermore pinpointed to specific local genomic regions. Results: Hypothyroidism was positively associated with an increased risk of major depressive disorder (MDD; OR = 1.31, p = 5.29 × 10-89), BIP (OR = 1.55, p = 0.0038), and ANX (OR = 1.16, p = 6.22 × 10-8). Hyperthyroidism was associated with MDD (OR = 1.11, p = 0.0034) and ANX (OR = 1.34, p = 5.99 × 10-⁶). Genetically, strong coheritability was observed between thyroid disease and both major depressive (rg = 0.17, p = 2.7 × 10-⁴) and ANXs (rg = 0.17, p = 6.7 × 10-⁶). This genetic correlation was particularly strong at the major histocompatibility complex locus on chromosome 6 (p < 10-⁵), but further analysis showed that other parts of the genome also contributed to this global effect. Importantly, neither TSH nor fT4 levels were genetically correlated with mood disorders. Conclusions: Our findings highlight an underlying association between autoimmune hypothyroidism and mood disorders, which is not mediated through THs and in which autoimmunity plays a prominent role. While these findings could shed new light on the potential ineffectiveness of treating (minor) variations in thyroid function in psychiatric disorders, further research is needed to identify the exact underlying molecular mechanisms.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Soheili-Nezhad S, Sprooten E, Tendolkar I, et al. Exploring the Genetic Link Between Thyroid Dysfunction and Common Psychiatric Disorders: A Specific Hormonal or a General Autoimmune Comorbidity. Thyroid. 2023. PMID: 36463425. doi:10.1089/thy.2022.0304

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。